Your browser doesn't support javascript.
loading
SensiPath: computer-aided design of sensing-enabling metabolic pathways.
Delépine, Baudoin; Libis, Vincent; Carbonell, Pablo; Faulon, Jean-Loup.
Afiliación
  • Delépine B; iSSB, Genopole, CNRS, UEVE, Université Paris Saclay, 91000 Évry, France Micalis Institute, INRA, AgroParisTech, Université Paris Saclay, 78350 Jouy-en-Josas, France.
  • Libis V; iSSB, Genopole, CNRS, UEVE, Université Paris Saclay, 91000 Évry, France Micalis Institute, INRA, AgroParisTech, Université Paris Saclay, 78350 Jouy-en-Josas, France.
  • Carbonell P; SYNBIOCHEM Centre, Manchester Institute of Biotechnology, University of Manchester, M1 7DN Manchester, UK.
  • Faulon JL; iSSB, Genopole, CNRS, UEVE, Université Paris Saclay, 91000 Évry, France Micalis Institute, INRA, AgroParisTech, Université Paris Saclay, 78350 Jouy-en-Josas, France SYNBIOCHEM Centre, Manchester Institute of Biotechnology, University of Manchester, M1 7DN Manchester, UK jlfaulon@jouy.inra.fr.
Nucleic Acids Res ; 44(W1): W226-31, 2016 07 08.
Article en En | MEDLINE | ID: mdl-27106061
ABSTRACT
Genetically-encoded biosensors offer a wide range of opportunities to develop advanced synthetic biology applications. Circuits with the ability of detecting and quantifying intracellular amounts of a compound of interest are central to whole-cell biosensors design for medical and environmental applications, and they also constitute essential parts for the selection and regulation of high-producer strains in metabolic engineering. However, the number of compounds that can be detected through natural mechanisms, like allosteric transcription factors, is limited; expanding the set of detectable compounds is therefore highly desirable. Here, we present the SensiPath web server, accessible at http//sensipath.micalis.fr SensiPath implements a strategy to enlarge the set of detectable compounds by screening for multi-step enzymatic transformations converting non-detectable compounds into detectable ones. The SensiPath approach is based on the encoding of reactions through signature descriptors to explore sensing-enabling metabolic pathways, which are putative biochemical transformations of the target compound leading to known effectors of transcription factors. In that way, SensiPath enlarges the design space by broadening the potential use of biosensors in synthetic biology applications.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Algoritmos / Programas Informáticos / Técnicas Biosensibles / Redes y Vías Metabólicas / Ingeniería Metabólica Tipo de estudio: Prognostic_studies Idioma: En Revista: Nucleic Acids Res Año: 2016 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Algoritmos / Programas Informáticos / Técnicas Biosensibles / Redes y Vías Metabólicas / Ingeniería Metabólica Tipo de estudio: Prognostic_studies Idioma: En Revista: Nucleic Acids Res Año: 2016 Tipo del documento: Article País de afiliación: Francia